CKD-828 Telmisartan Non-Responder Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 183 participants.
Also called NCT01426100
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 183 participants
- Registry
-
NCT01426100
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01426100. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CKD-828 Telmisartan Non-Responder Trial
- Condition
- Hypertension
- Intervention (Drug)
- CKD-828 40/2.5mg
- Intervention (Drug)
- CKD-828 40/5mg
- Intervention (Drug)
- Telmisartan 80mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01426100- Content hash
0712acd3dd15e8d2ddf0ab6eb00753758a189ee76aaad2cee529dcb87570697d